Dyadic Applied BioSolutions (“Dyadic”) (NASDAQ: DYAI) , a global biotechnology company producing precision-engineered, animal-free proteins and enzymes across life science, food & nutrition, and ...

Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company ...

Protalix BioTherapeutics, Inc. , a biopharmaceutical company focused on the discovery, development, production and ...

Cell-line development enhances biopharmaceutical production capacity and quality, but complex biologics like bsAbs and ADCs ...

Dyadic Applied BioSolutions ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company producing precision-engineered ...

The agreement also allows both parties to incorporate products developed on Fermbox Bio’s microbial platforms into the joint portfolio.

Chitose Laboratory Corp., (CHITOSE), a leading company of the bioeconomy and provider of advanced cell line development ...

Diabetes goes beyond just glucose control, and recent advancements in research are enhancing drug development for the disease.

Collagenase-like protease (Clp) enhances the toxic effect of Streptococcus suis serotype 2 (SS2). Clp increases the permeability of the blood–brain barrier by disrupting tight junctions and inducing ...

The central pathology of APOEε4 involves a vicious cycle of lipid metabolism disorders and neuroinflammation. Consequently, upregulating lipidation transporters, such as ABCA1, to improve APOEε4's ...

Arpita Bose and Zhecheng Zhang explore genetic tools in environmental microbes, citing applications in extracellular electron transfer ...

The "IVD Raw Materials - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for IVD Raw Materials was valued at US$27.7 Billion in 2024 and is ...